Who is sponsoring NCT03834649?

NCT03834649 is sponsored by Nouran Abdulla Mater,MD.

What drugs are being tested in NCT03834649?

Interventions in NCT03834649: partially de-epithelized connective tissue graft, Mucograft.

What condition does NCT03834649 study?

NCT03834649 studies Alveolar Bone Loss.

Is NCT03834649 still recruiting?

NCT03834649 is currently status unknown. Last updated 11 February 2019.

Last reviewed 2019-02-11 · How we verify

NCT03834649

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pontic Site Development Using Soft Tissue Augmentation

Status unknown Phase 3 Last updated 11 February 2019

What this trial tests

Phase 3 trial testing partially de-epithelized connective tissue graft in Alveolar Bone Loss in 24 participants. Status unknown.

Timeline

1 February 2019

Primary endpoint
25 August 2020

25 September 2020

Quick facts

Lead sponsor	Nouran Abdulla Mater,MD
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	24
Start date	1 February 2019
Primary completion	25 August 2020
Estimated completion	25 September 2020
Sites	1 location across Egypt

Drugs / interventions tested

partially de-epithelized connective tissue graft
Mucograft — full drug profile →

Conditions studied

Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Nouran Abdulla Mater,MD

Who can join

Adults 19 to 50, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

in patients with vertical or horizontal defective of there ridge it is difficult to have prosthetic restoration with natural appearance emetating and simulating the adjacent abutment emergence profile so this study aims to develop the defective area using two different materials of soft tissue grafting techniques to restore the missing tissue and regain soft tissue volume and profile

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
NCT07449806 — Assessment of Labial Plate Thickness After Immediate Implant Placement Using Two Different Xenografts in the Esthetic Zo · NA · recruiting
NCT07419269 — Comparison of Customized Allogenic Versus Autogenous Bone Block Graft for Alveolar Ridge Augmentation · NA · recruiting
NCT06887582 — Crestal Sinus Lifting in Periodontally-Compromised Patients Utilizing Autologous Dentin Graft · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03834649 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nouran Abdulla Mater,MD
Last refreshed: 11 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03834649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing